{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:49:09Z","timestamp":1790336949053,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:00:00Z","timestamp":1447027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","award":["15662"],"award-info":[{"award-number":["15662"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","award":["REG-NC-002"],"award-info":[{"award-number":["REG-NC-002"]}],"id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1378\/chest.15-0928","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T09:32:46Z","timestamp":1445506366000},"page":"1061-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Hemodynamic Thresholds for Precapillary Pulmonary Hypertension"],"prefix":"10.1016","volume":"149","author":[{"given":"Christian","family":"Gerges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Skoro-Sajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roela","family":"Sadushi-Kolici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Jakowitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie B.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1378\/chest.15-0928_bib1","first-page":"44","article-title":"A\u00a0randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am\u00a0Heart J"},{"issue":"21","key":"10.1378\/chest.15-0928_bib2","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.0000038497.80095.E1","article-title":"Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT)","volume":"106","author":"Luscher","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"10.1378\/chest.15-0928_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1378\/chest.15-0928_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1378\/chest.15-0928_bib5","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest"},{"issue":"25\u00a0suppl","key":"10.1378\/chest.15-0928_bib6","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart\u00a0diseases","volume":"62","author":"Vachiery","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1378\/chest.15-0928_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1152\/jappl.1949.2.1.24","article-title":"Pulmonary capillary pressure in man","volume":"2","author":"Hellems","year":"1949","journal-title":"J\u00a0Appl Physiol"},{"issue":"5","key":"10.1378\/chest.15-0928_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1378\/chest.15-0928_bib9","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1378\/chest.15-0928_bib10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-1653","article-title":"Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in\u00a0\u201cout-of-proportion\u201d pulmonary hypertension","volume":"143","author":"Gerges","year":"2013","journal-title":"Chest"},{"issue":"10","key":"10.1378\/chest.15-0928_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201503-0529OC","article-title":"Pulmonary hypertension in heart failure: epidemiology, right ventricular function and survival","volume":"192","author":"Gerges","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.15-0928_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.00074312","article-title":"The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease","volume":"41","author":"Naeije","year":"2013","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.15-0928_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jchf.2014.12.015","article-title":"Characterization of pulmonary hypertension in heart failure using the\u00a0diastolic pressure gradient: the conundrum of high and low diastolic pulmonary gradient","volume":"3","author":"Gerges","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1378\/chest.15-0928_bib14","doi-asserted-by":"crossref","first-page":"H1731","DOI":"10.1152\/ajpheart.00336.2006","article-title":"Quantification of right ventricular afterload in patients with and without pulmonary hypertension","volume":"291","author":"Lankhaar","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1378\/chest.15-0928_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1378\/chest.15-0928_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"issue":"24","key":"10.1378\/chest.15-0928_bib17","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1378\/chest.15-0928_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jacc.2005.09.054","article-title":"Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension","volume":"47","author":"Mahapatra","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1378\/chest.15-0928_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1183\/09031936.00209313","article-title":"Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension","volume":"44","author":"LeVarge","year":"2014","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1378\/chest.15-0928_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201402-0269PP","article-title":"Reading pulmonary vascular pressure tracings: how to handle the problems of zero leveling and respiratory swings","volume":"190","author":"Kovacs","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"25\u00a0suppl","key":"10.1378\/chest.15-0928_bib21","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25\u00a0suppl","key":"10.1378\/chest.15-0928_bib22","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1378\/chest.15-0928_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00005344-200302000-00019","article-title":"Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension","volume":"41","author":"McLaughlin","year":"2003","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"6","key":"10.1378\/chest.15-0928_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in\u00a0patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.15-0928_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.healun.2009.09.005","article-title":"Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial","volume":"29","author":"Hiremath","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1378\/chest.15-0928_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1378\/chest.67.1.1","article-title":"Assessment of acute respiratory failure: cardiac versus pulmonary causes","volume":"67","author":"Stevens","year":"1975","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.15-0928_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"3","key":"10.1378\/chest.15-0928_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.healun.2014.08.020","article-title":"Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance","volume":"34","author":"Farber","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1378\/chest.15-0928_bib29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1378\/chest.15-0928_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1378\/chest.12-0270","article-title":"Baseline and follow-up 6-min walk distance and\u00a0brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension","volume":"143","author":"Fritz","year":"2013","journal-title":"Chest"},{"issue":"13","key":"10.1378\/chest.15-0928_bib31","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacc.2012.01.083","article-title":"Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials","volume":"60","author":"Savarese","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1378\/chest.15-0928_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCULATIONAHA.112.105890","article-title":"Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials","volume":"126","author":"Gabler","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.15-0928_bib33","first-page":"251","article-title":"Primary pulmonary hypertension: follow-up of patients with and without anorectic drug intake","volume":"22","author":"Mlczoch","year":"1980","journal-title":"Cor Vasa"},{"issue":"4","key":"10.1378\/chest.15-0928_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ahj.2012.01.024","article-title":"Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension","volume":"163","author":"Ryan","year":"2012","journal-title":"Am Heart J"},{"issue":"1","key":"10.1378\/chest.15-0928_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.08-2784","article-title":"Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure","volume":"136","author":"Halpern","year":"2009","journal-title":"Chest"},{"key":"10.1378\/chest.15-0928_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1387","article-title":"Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18\u00a0mm\u00a0Hg: insights from the REVEAL Registry","volume":"143","author":"Frost","year":"2013","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.15-0928_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.healun.2013.11.008","article-title":"Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension","volume":"33","author":"Tedford","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1378\/chest.15-0928_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchf.2014.07.010","article-title":"The diastolic pulmonary gradient does not\u00a0predict survival in patients with pulmonary hypertension due to left heart disease","volume":"3","author":"Tampakakis","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"15","key":"10.1378\/chest.15-0928_bib39","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1378\/chest.15-0928_bib40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1378\/chest.15-0928_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T11:04:50Z","timestamp":1692097490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0012369215000690"],"URL":"https:\/\/doi.org\/10.1378\/chest.15-0928","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725869066.793510675","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemodynamic Thresholds for Precapillary Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.15-0928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}